Clinical Study Results
Research Sponsor: MedImmune, LLC
Drug Studied: MEDI3250 vaccine
Study Title: A study to learn more about the safety of the MEDI3250
flu vaccine
Thank you!
Thank you to the participants in the clinical study for the vaccine MEDI3250. All
of the participants helped researchers learn more about using the study vaccine
to prevent influenza, also known as the flu. MedImmune, LLC sponsored this
study and thinks it is important to share the results. An independent non-profit
organization called CISCRP helped prepare this summary of the study results.
If you participated in the study and have questions about the results, please speak
with the doctor or staff at your study site.
What is happening with the study now?
The study has finished. The participants were in the study for about 6 months and
the entire study took up to 7 months to finish.
The study started in June 2018 and ended in December 2018. The study included
300 participants in the United States.
The sponsor reviewed the data collected when the study ended and created a
report of the results. This is a summary of that report.
1